Post Market - Sensex falls 202 points, Nifty ends below 14,350
Stocks in the news -
1. Alembic Pharma gets USFDA nod for Doxepin Hydrochloride Capsules, used to treat depression & anxiety
2. Caplin Steriles received USFDA approval for Prochlorperazine Edisylate Injection.
Indian indices -
The benchmark indices ended lower on April 23, dragged by selling in IT, FMCG and pharma stocks. The Sensex closed at 47,878.45, down 202.22 points, or 0.42%, while the Nifty was at 14,341.35, down 64.80 points, or 0.45%.
The market breadth was in favour of advances with an advance-decline ratio of 5:4.
Buzzing stocks on BSE -
1. Tata Elxsi jumped by 4.78% to Rs. 3,191.95, after the company's net profit increased by 9.5% to Rs 115.2 crore in Q4 FY21.
2. Cadila Healthcare rose by 3.43% to Rs. 571.20, after the company received emergency use approval from India's drug regulator for the use of Pegylated Interferon alpha-2b, 'Virafin' in treating moderate COVID-19 infection in adults.
Global Signals -
European markets were little changed on April 23. as global stocks search for direction to end the week, with investors monitoring a slew of economic data and corporate earnings.
Asian stock markets were mixed on April 23, after Wall Street fell following a report that President Joe Biden will propose raising taxes on wealthy investors.
No comments:
Post a Comment